(Q40184738)

18 September 2017

title

COX-2 involvement in breast cancer metastasis to bone (English)

1 reference

18 September 2017

1 reference

Singh B

1

1 reference

18 September 2017

Berry JA

2

1 reference

18 September 2017

Shoher A

3

1 reference

18 September 2017

Ayers GD

4

1 reference

18 September 2017

Wei C

5

1 reference

18 September 2017

Lucci A

6

1 reference

18 September 2017

language of work or name

English

0 references

publication date

8 January 2007

1 reference

18 September 2017

1 reference

18 September 2017

volume

26

1 reference

18 September 2017

issue

26

1 reference

18 September 2017

page(s)

3789-3796

1 reference

Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDO.

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Interleukin-11: a new cytokine critical for osteoclast development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Role of Val509 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

MDA-MB-435 human breast carcinoma metastasis to bone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

COX-2 inhibitors for the prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

A multigenic program mediating breast cancer metastasis to bone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Breast cancer and NSAID use: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Cyclooxygenase inhibitors modulate NK activities that control metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Increased cyclooxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Antimetastatic activity of a cyclooxygenase-2 inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Role of cyclooxygenase-2 in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

COX-2 induces IL-11 production in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Cyclooxygenase-2: a potential target in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Vitamin E analog alpha-TEA and celecoxib alone and together reduce human MDA-MB-435-FL-GFP breast cancer burden and metastasis in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210154

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210154

1 reference

Dimensions Publication ID

18 September 2017

1020638697

0 references

1 reference